In principle, the increased expression of ACHE in COVID-19 non-survivors and the increased expression of CLEC12A in COVID-19 survivors could be due to either COVID-19 itself or might represent an unknown predisposing factor for the development of severe COVID-19. Here, CLEC12A is linked to COVID-19.